Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Boekholdt

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
A guideline for uniform and optimal atherosclerotic risk factor assessment across clinical specialities in a large hospitalS M Boekholdt, R J G Peters
Nederlands Tijdschrift Voor Geneeskunde|December 29, 2007
[The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant]S M Boekholdt, J W Jukema, R J G Peters
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 20, 2020
Different road maps for ventricular tachycardia ablationL R A Olde Nordkamp, S M Boekholdt, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 2, 2012
Percutaneous treatment of native aortic coarctation in adultsP Luijendijk, S M Boekholdt, B J M Mulder, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 13, 2016
The Dutch SCORE-based risk charts seriously underestimate the risk of cardiovascular diseaseH T Jørstad, S M Boekholdt, N J Wareham, et al.
Circulation|December 19, 2001
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic reviewS M Boekholdt, N R Bijsterveld, A H Moons, et al.
Journal of Thrombosis and Haemostasis : JTH|August 3, 2006
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population studyS M Boekholdt, M S Sandhu, N J Wareham, et al.
Current Opinion in Lipidology|November 6, 2004
Role of CETP inhibitors in the treatment of dyslipidemiaW A van der Steeg, J A Kuivenhoven, A H Klerkx, et al.
International Journal of Cardiology|June 17, 2017
Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."J Neefs, N W E van den Berg, J Limpens, et al.
International Journal of Cardiology|January 8, 2017
Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-AnalysisJ Neefs, N W E van den Berg, J Limpens, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
A guideline for uniform and optimal atherosclerotic risk factor assessment across clinical specialities in a large hospitalS M Boekholdt, R J G Peters
Nederlands Tijdschrift Voor Geneeskunde|December 29, 2007
[The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant]S M Boekholdt, J W Jukema, R J G Peters
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 20, 2020
Different road maps for ventricular tachycardia ablationL R A Olde Nordkamp, S M Boekholdt, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 2, 2012
Percutaneous treatment of native aortic coarctation in adultsP Luijendijk, S M Boekholdt, B J M Mulder, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 13, 2016
The Dutch SCORE-based risk charts seriously underestimate the risk of cardiovascular diseaseH T Jørstad, S M Boekholdt, N J Wareham, et al.
Circulation|December 19, 2001
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic reviewS M Boekholdt, N R Bijsterveld, A H Moons, et al.
Journal of Thrombosis and Haemostasis : JTH|August 3, 2006
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population studyS M Boekholdt, M S Sandhu, N J Wareham, et al.
Current Opinion in Lipidology|November 6, 2004
Role of CETP inhibitors in the treatment of dyslipidemiaW A van der Steeg, J A Kuivenhoven, A H Klerkx, et al.
International Journal of Cardiology|June 17, 2017
Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."J Neefs, N W E van den Berg, J Limpens, et al.
International Journal of Cardiology|January 8, 2017
Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-AnalysisJ Neefs, N W E van den Berg, J Limpens, et al.
Pageof 5